The bentonite/zeolite 4A nanocomposite exerts synergistic cytotoxic effects in melanoma cells. While the results highlight its therapeutic potential, further mechanistic studies are required to clarify the underlying pathways prior to clinical translation.
Duman et al. (Fri,) studied this question.